Silver Book Fact

Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.

Califf R, Harrington R, Madre L, Peterson E, et al. Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics. Health Affairs. 2007; 26(1): 62-74. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.62

Reference

Title
Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Califf R, Harrington R, Madre L, Peterson E, et al.
Volume & Issue
Volume 26, Issue 1
Pages
62-74
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Aspirin use in AFib patients
    Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients reduced stroke risk by an average 22%.  
  • “Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire…  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.  
  • Statin treatment soon after an acute heart attack reduces the risk of fatal heart disease or a recurrent heart attack by 24%.  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.